Attending The 2023 SNO/ASC CNS Cancer Conference

Conferences
Written By Michael Abrahamson
Richard Austin stands next to poster for 2023 SNO/ASCO CNS Cancer Conference in San Francisco August 10th to 12th.

Reglagene's CEO Richard Austin is attending the 2023 SNO/ASCO CNS Cancer Conference. Please reach out to Dr. Austin if you are attending and would like to connect!

Michael Abrahamson
Previous

Richard Austin To Present At Keiretsu Forum Panel On Transforming Therapy For Brain Diseases
Next

Reglagene Gets Crucial Tech Coast Angels Funding For FDA Brain Cancer Therapy Studies